Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
Expert Review of Clinical Pharmacology
(ISSN: 1751-2433,1751-2441)
This journal no longer participates in Medscape Publishers' Circle Program. No new articles will be republished.
Treatment of infections in cancer patients: an update from the neutropenia, infection and myelosuppression study group of the Multinational Association for Supportive Care in Cancer (MASCC).
Radical metastasectomy followed by sorafenib versus observation in patients withclear cell renal cell carcinoma: extended follow -up of efficacy results from the randomized phase II RESORT trial.
The paradigm of norgestimate: a third-generation testosterone-derivative progestin with a peripheral anti-androgenic activity and the lowest risk of venous thromboembolism.
Response to letter to the editor re: 'serious adverse events and deaths in PCSK9 inhibitor trials reported on ClinicalTrials.gov: a systematic review'.
Mission Statement:
Expert Review of Clinical Pharmacology provides a forum for informed debate and critical analysis in all aspects of safety, tolerability, efficacy and therapeutic applications of existing and emerging therapies.